Targeting Cancer Signaling Pathways with Plant-Derived Agents: A Review

Authors

Tusharkumar Sangada

Department of Botany, Faculty of Science, Mehsana Urban Institute of Sciences (MUIS), Ganpat University, Mehsana, Gujarat (India)

Kishan Rathod

Department of Botany, Faculty of Science, Mehsana Urban Institute of Sciences (MUIS), Ganpat University, Mehsana, Gujarat (India)

Shivani Chaudhary

Department of Botany, Faculty of Science, Mehsana Urban Institute of Sciences (MUIS), Ganpat University, Mehsana, Gujarat (India)

Gautam Kardani

Department of Botany, Faculty of Science, Mehsana Urban Institute of Sciences (MUIS), Ganpat University, Mehsana, Gujarat (India)

Savankumar Donga

Department of Botany, Faculty of Science, Mehsana Urban Institute of Sciences (MUIS), Ganpat University, Mehsana, Gujarat (India)

Sucheta Karande

Department of Botany, Faculty of Science, Mehsana Urban Institute of Sciences (MUIS), Ganpat University, Mehsana, Gujara (India)

Article Information

DOI: 10.51584/IJRIAS.2026.110200138

Subject Category: Social science

Volume/Issue: 11/2 | Page No: 1488-1498

Publication Timeline

Submitted: 2026-02-21

Accepted: 2026-02-26

Published: 2026-03-19

Abstract

Cancer remains a global health challenge, and current therapies, including chemotherapy and radiation therapy, are often limited by serious side effects and drug resistance. These limitations have sparked increasing interest in natural alternatives, especially plant-based compounds with diverse biological actions. Several phytochemicals, such as curcumin, epigallocatechin-3-gallate (EGCG), withaferin-A, kaempferol, and quercetin, have been shown to inhibit important signaling pathways that cancer cells rely on for growth, survival, and metastasis. These natural agents, which often target multiple cellular pathways rather than a single target, as many drugs do, are particularly valuable in the fight against drug-resistant cancers. Nevertheless, their clinical use is limited by issues such as low bioavailability, distinct pharmacokinetics, and tumor heterogeneity. In view of these challenges, the utilization of innovative drug delivery methods, such as nano-functionalized formulations, along with combination strategies, has been considered in recent studies. This evidence gives way to the development of network pharmacology and personalized medicine as valuable strategies in maximizing the therapeutic activity of medicinal plants; This review explores the mechanisms by which these agents exert their anticancer activity and highlights progress made in, as well as hurdles remaining toward, the integration of these strategies into contemporary oncology.

Keywords

signalling, anticancer, pharmacology, curcumin

Downloads

References

1. Asgharian, P., Tazehkand, A. P., Soofiyani, S. R., Hosseini, K., Martorell, M., Tarhriz, V., Ahangari, H., Cruz-Martins, N., Sharifi-Rad, J., Almarhoon, Z. M., Ydyrys, A., Nurzhanyat, A., Yessenbekova, A., and Cho, W. C. (2021). Quercetin impact in pancreatic cancer: an overview on its therapeutic effects. Wiley Online LibraryP Asgharian, AP Tazehkand, SR Soofiyani, K Hosseini, M Martorell, V Tarhriz, H AhangariOxidative Medicine and Cellular Longevity, 2021•Wiley Online Library, 2021. https://doi.org/10.1155/2021/4393266 [Google Scholar] [Crossref]

2. Bouyahya, A., Mechchate, H., Oumeslakht, L., Zeouk, I., Aboulaghras, S., Balahbib, A., Zengin, G., Kamal, M. A., Gallo, M., Montesano, D., and El Omari, N. (2022). The role of epigenetic modifications in human cancers and the use of natural compounds as epidrugs: Mechanistic pathways and pharmacodynamic actions. Mdpi.ComA Bouyahya, H Mechchate, L Oumeslakht, I Zeouk, S Aboulaghras, A Balahbib, G ZenginBiomolecules, 2022•mdpi.Com, 12(3). https://doi.org/10.3390/BIOM12030367 [Google Scholar] [Crossref]

3. Tarik Regad. (2015). Targeting RTK signaling pathways in cancer. Mdpi.ComT RegadCancers, 2015•mdpi.Com, 7(3), 1758–1784. https://doi.org/10.3390/CANCERS7030860 [Google Scholar] [Crossref]

4. Chirumbolo, S., Bjørklund, G., Lysiuk, R., Vella, A., Lenchyk, L., & Upyr, T. (2018). Targeting cancer with phytochemicals via their fine tuning of the cell survival signaling pathways. Mdpi.ComS Chirumbolo, G Bjørklund, R Lysiuk, A Vella, L Lenchyk, T Upyr International Journal of Molecular Sciences, 2018•mdpi.Com, 19(11). https://doi.org/10.3390/IJMS19113568 [Google Scholar] [Crossref]

5. Choi, E. J., Ryu, Y. K., Kim, S. Y., Wu, H. G., Kim, J. S., Kim, I. H., and Kim, I. A. (2010). Targeting epidermal growth factor receptor–associated signaling pathways in non–small cell lung cancer cells: Implication in radiation response. Aacrjournals.OrgEJ Choi, YK Ryu, SY Kim, HG Wu, JS Kim, IH Kim, IA KimMolecular Cancer Research, 2010•aacrjournals.Org, 8(7), 1027–1036. https://doi.org/10.1158/1541-7786.MCR-09-0507 [Google Scholar] [Crossref]

6. Denlinger, C. E., Rundall, B. K., and Jones, D. R. (2004). Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-κB. Elsevier, 16(1), 28–39. https://doi.org/10.1053/J.SEMTCVS.2003.12.004/ASSET/BCF95FED-38CD-4EC0-B3B5-F994F72FD3F2/MAIN.ASSETS/GR4.SML [Google Scholar] [Crossref]

7. Farghadani, R., Naidu, R., Farghadani, R., and Naidu, R. (2021). Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer. Cancers 2021, Vol. 13, 13(14). https://doi.org/10.3390/CANCERS13143427 [Google Scholar] [Crossref]

8. Farooqi, A. A., Pinheiro, M., Granja, A., Farabegoli, F., Reis, S., Attar, R., Uteuliyev, Y. S., Xu, B., and Ahmad, A. (2020). EGCG mediated targeting of deregulated signaling pathways and non-coding RNAs in different cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD. Mdpi.ComAA Farooqi, M Pinheiro, A Granja, F Farabegoli, S Reis, R Attar, UY Sabitaliyevich, B XuCancers, 2020•mdpi.Com, 12(4). https://doi.org/10.3390/CANCERS12040951 [Google Scholar] [Crossref]

9. Jenča, A., Mills, D. K., Ghasemi, H., Saberian, E., Forood, A. M. K., Petrášová, A., Jenčová, J., Velisdeh, Z. J., Zare-Zardini, H., and Ebrahimifar, M. (2024). Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy. Biologics : Targets & Therapy, 18, 229–255. https://doi.org/10.2147/BTT.S484068 [Google Scholar] [Crossref]

10. Lee, I. C., and Choi, B. Y. (2016). Withaferin-A—A Natural Anticancer Agent with Pleitropic Mechanisms of Action. International Journal of Molecular Sciences 2016, Vol. 17, Page 290, 17(3), 290. https://doi.org/10.3390/IJMS17030290 [Google Scholar] [Crossref]

11. Liu, L. H., Shi, R. J., and Chen, Z. C. (2020). Paeonol exerts anti-tumor activity against colorectal cancer cells by inducing G0/G1 phase arrest and cell apoptosis via inhibiting the Wnt/β-catenin signaling pathway. International Journal of Molecular Medicine, 46(2), 675–684. https://doi.org/10.3892/IJMM.2020.4629/DOWNLOAD [Google Scholar] [Crossref]

12. Mohan Shankar, G., Swetha, M., Keerthana, C. K., Rayginia, T. P., & Anto, R. J. (2022). Cancer Chemoprevention: A Strategic Approach Using Phytochemicals. Frontiers in Pharmacology, 12. https://doi.org/10.3389/FPHAR.2021.809308/FULL [Google Scholar] [Crossref]

13. Mondal, A., Nayak, A. K., Chakraborty, P., Banerjee, S., & Nandy, B. C. (2023). Natural polymeric nanobiocomposites for anti-cancer drug delivery therapeutics: A recent update. Mdpi.ComA Mondal, AK Nayak, P Chakraborty, S Banerjee, BC NandyPharmaceutics, 2023•mdpi.Com, 15(8). https://doi.org/10.3390/PHARMACEUTICS15082064 [Google Scholar] [Crossref]

14. Edward R Sauter (2020). Cancer prevention and treatment using combination therapy with natural compounds. Taylor & FrancisER SauterExpert Review of Clinical Pharmacology, 2020•Taylor & Francis, 13(3), 265–285. https://doi.org/10.1080/17512433.2020.1738218 [Google Scholar] [Crossref]

15. Qattan, M. Y., Khan, M. I., Alharbi, S. H., Verma, A. K., Al-Saeed, F. A., Abduallah, A. M., & Al Areefy, A. A. (2022). Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways. Molecules 2022, Vol. 27, Page 8864, 27(24), 8864. https://doi.org/10.3390/MOLECULES27248864 [Google Scholar] [Crossref]

16. Shrihastini, V., Muthuramalingam, P., Adarshan, S., Sujitha, M., Chen, J. T., Shin, H., & Ramesh, M. (2021). Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview. Cancers, 13(24), 6222. https://doi.org/10.3390/CANCERS13246222 [Google Scholar] [Crossref]

17. Siddiqui, A. J., Alshammari, A. M., Patel, M., Ghoniem, A. E. M., Siddiqui, M. A., Abdalla, R. A. H., Ghorbel, M., Badraoui, R., Bardakci, F., & Adnan, M. (2025). Anti-cancer effects of Plumbago zeylanica L. against human triple-negative breast cancer: Insights from network pharmacology and in-vitro experimental validation. South African Journal of Botany, 180, 795–810. https://doi.org/10.1016/J.SAJB.2025.03.051 [Google Scholar] [Crossref]

18. Singh, V. Kumar., Singh, A. Kumar., & Garg, Neha. (2026). Plant-derived anticancer drugs. https://onlinelibrary.wiley.com/doi/abs/10.1002/9781394300594.fmatter. https://doi.org/10.1002/9781394300594.fmatter [Google Scholar] [Crossref]

19. Tilaoui, M., Ait Mouse, H., & Zyad, A. (2021). Update and New Insights on Future Cancer Drug Candidates From Plant-Based Alkaloids. Frontiers in Pharmacology, 12. https://doi.org/10.3389/FPHAR.2021.719694/FULL [Google Scholar] [Crossref]

20. Tsai, F. S., Lin, L. W., & Wu, C. R. (2016). Lupeol and its role in chronic diseases. Advances in Experimental Medicine and Biology, 929, 145–175. https://doi.org/10.1007/978-3-319-41342-6_7 [Google Scholar] [Crossref]

21. Uzoigwe, J., (2012). Cancer prevention and treatment using combination therapy with plant-and animal-derived compounds. Taylor & FrancisJ Uzoigwe, ER SauterExpert Review of Clinical Pharmacology, 2012•Taylor & Francis, 5(6), 701–709. https://doi.org/10.1586/ECP.12.62 [Google Scholar] [Crossref]

22. Wang, X., Semba, T., Phi, L. T. H., Chainitikun, S., Iwase, T., Lim, B., & Ueno, N. T. (2020). Targeting signaling pathways in inflammatory breast cancer. Mdpi.ComX Wang, T Semba, LTH Phi, S Chainitikun, T Iwase, B Lim, NT UenoCancers, 2020•mdpi.Com, 12(9), 1–19. https://doi.org/10.3390/CANCERS12092479 [Google Scholar] [Crossref]

23. Yang, M. H., Baek, S. H., Ha, I. J., Um, J. Y., & Ahn, K. S. (2021). Brassinin enhances the anticancer actions of paclitaxel by targeting multiple signaling pathways in colorectal cancer cells. Wiley Online LibraryMH Yang, SH Baek, IJ Ha, JY Um, KS AhnPhytotherapy Research, 2021•Wiley Online Library, 35(7), 3875–3885. https://doi.org/10.1002/PTR.7095 [Google Scholar] [Crossref]

24. Zheng, J., Wu, M., Wang, H., Li, S., Wang, X., Li, Y., Wang, D., & Li, S. (2018). Network pharmacology to unveil the biological basis of health-strengthening herbal medicine in cancer treatment. Mdpi.Com, 10(11). https://doi.org/10.3390/CANCERS10110461 [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles